Srinija Drugs Private Limited, a active private limited company, was established on 17 April 2000 in Andhra Pradesh, Andhra Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233AP2000PTC034263. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹6.00 M.
It upholds a compliant status. Employing 19 professional, Its leadership includes Nekkanti Saraswathi (Director), Venkata Satyavani Donavalli (Director), Anantha Laxmi Talluri (Director). It holds ₹2.44 Cr open charges and ₹1.24 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at P.N.245, Ida,Kondapally Vijayawada, Andhra Pradesh, Andhra Pradesh, 521228.
U24233AP2000PTC034263
034263
17 April 2000
₹7.50 M
₹6.00 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Srinija Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nekkanti Saraswathi | Director | 28 Oct 2023 | Current |
| Venkata Satyavani Donavalli | Director | 28 Oct 2023 | Current |
| Anantha Laxmi Talluri | Director | 28 Oct 2023 | Current |
| Laxmanarao Talluri | Director | 17 Apr 2000 | Current |
| Venkata Ramesh Donavalli | Director | 17 Apr 2000 | Current |
| Bulli Raju Nekkanti | Managing Director | 17 Apr 2000 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Srinija Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.46% decrease. The company also saw a substantial fall in profitability, with a 46.13% decrease in profit. The company's net worth Soared by an impressive increase of 10.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Srinija Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹24,448,000.00
₹12,400,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Sep 2014 | Others | ₹2.44 Cr | Open |
| 12 Aug 2011 | Oriental Bank Of Commerce | ₹9.00 M | Satisfied |
| 01 Mar 2006 | Indusind Bank | ₹3.40 M | Satisfied |
Explore comprehensive loan charge details -
Srinija Drugs has a workforce of 19 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Srinija Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srinija Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Srinija Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Srinija Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was documented.
The activity Nekkanti Saraswathi was appointed as a Director was appointed as a Director on 28 Oct 2023 & has been associated with this company since 2 years 2 months . was completed.
The activity Venkata Satyavani Donavalli was appointed as a Director was appointed as a Director on 28 Oct 2023 & has been associated with this company since 2 years 2 months . was completed.
The activity Anantha Laxmi Talluri was appointed as a Director was appointed as a Director on 28 Oct 2023 & has been associated with this company since 2 years 2 months . was completed.
Progress on A charge with Others of Rs. 24.45 M registered on 08 Sep 2014 with Charge ID 10521262 was modified on 28 Oct 2022. was documented.
The CIN of Srinija Drugs Private Limited is U24233AP2000PTC034263.
Srinija Drugs Private Limited is headquartered at P.N.245, Ida,Kondapally Vijayawada, Andhra Pradesh, Andhra Pradesh, 521228.
Srinija Drugs Private Limited was incorporated on 17 April 2000.
The current directors of Srinija Drugs Private Limited are
The primary industry of Srinija Drugs Private Limited is Manufacturing.
Srinija Drugs Private Limited is unlisted.
The authorized capital of Srinija Drugs Private Limited is ₹7.50 M, and the paid-up capital is ₹6.00 M.
The compliance status of Srinija Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX